Clinical Trials Logo

Clinical Trial Summary

The current intake of dietary fiber by children in France and Europe is below established nutritional recommendations. Therefore, promoting fiber consumption from childhood as part of a diversified diet is crucial. For over 20 years, the food industry has been using scFOS (short-chain fructo-oligosaccharides), a fiber produced from sugar beet, as an additional source of dietary fiber. This solution can help increase daily fiber intake, meet nutritional recommendations, and provide positive health effects. Although scFOS are commonly used, there has not yet been a prospective study specifically on children aged 6 to 12 to assess gastrointestinal comfort following their regular consumption at dietary doses of 10-20 g per day. The European Food Safety Authority (EFSA) recommends that all manufacturers document the safety of food ingredients (EFSA, 2021). This is based on Directive 2002/46/EC, which states that substances added to foods, including those intended for specific groups, must be safe and bioavailable. The study aims to assess gastrointestinal comfort and scFOS tolerance in children aged 6 to 12 and is fully compliant with Directive 2002/46/EC and EFSA recommendations.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT06204978
Study type Interventional
Source Tereos
Contact
Status Completed
Phase N/A
Start date November 30, 2022
Completion date December 20, 2023

See also
  Status Clinical Trial Phase
Active, not recruiting NCT02732301 - Postoperative Gastrointestinal Dysfunction After Cardiac Surgery - Occurrence and Search for Biomarkers
Completed NCT01276483 - Treatment Response Evaluation in Gastrointestinal Stromal Tumor (GIST) Patients N/A
Active, not recruiting NCT04758715 - Diet and Microbiome Longitudinal Monitoring With Food Intervention N/A
Completed NCT02884154 - Feasibility and Yield of a New 20 G ProCore Needle With Coiled Sheath in the Gastrointestinal Subepithelial Tumors N/A
Completed NCT02562404 - Vagus Nerve Injury Post Radiofrequency Catheter Ablation for Atrial Fibrillation N/A
Completed NCT02423551 - MRE Consumption and Gut Health N/A